Suppr超能文献

CD8(+) T细胞在急性乙型肝炎病毒感染期间介导病毒清除和疾病发病机制。

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

作者信息

Thimme Robert, Wieland Stefan, Steiger Carola, Ghrayeb John, Reimann Keith A, Purcell Robert H, Chisari Francis V

机构信息

Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.

出版信息

J Virol. 2003 Jan;77(1):68-76. doi: 10.1128/jvi.77.1.68-76.2003.

Abstract

Although the CD4(+)- and CD8(+)-T-cell responses to the hepatitis B virus (HBV) are thought to be crucial for the control of HBV infection, the relative contribution of each T-cell subset as an effector of viral clearance is not known. To examine this question, we monitored the course of HBV infection in control, CD4-depleted, and CD8-depleted chimpanzees. Our results demonstrate that CD8(+) cells are the main effector cells responsible for viral clearance and disease pathogenesis during acute HBV infection, and they suggest that viral clearance is mediated by both noncytolytic and cytolytic effector functions of the CD8(+)-T-cell response.

摘要

虽然人们认为CD4(+)和CD8(+) T细胞对乙型肝炎病毒(HBV)的反应对于控制HBV感染至关重要,但每个T细胞亚群作为病毒清除效应器的相对贡献尚不清楚。为了研究这个问题,我们监测了对照、CD4细胞耗竭和CD8细胞耗竭的黑猩猩中HBV感染的过程。我们的结果表明,CD8(+)细胞是急性HBV感染期间负责病毒清除和疾病发病机制的主要效应细胞,并且表明病毒清除是由CD8(+) T细胞反应的非细胞溶解和细胞溶解效应功能介导的。

相似文献

2
CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
J Immunol. 2010 Jan 1;184(1):287-95. doi: 10.4049/jimmunol.0902761. Epub 2009 Nov 30.
3
[The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
Z Gastroenterol. 2004 Jan;42(1):39-46. doi: 10.1055/s-2004-812688.
5
Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees.
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2129-34. doi: 10.1073/pnas.0308478100. Epub 2004 Feb 5.
6
NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
J Immunol. 2016 May 15;196(10):4122-31. doi: 10.4049/jimmunol.1500846. Epub 2016 Apr 20.
7
Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Gastroenterology. 2008 Jun;134(7):1938-49, 1949.e1-3. doi: 10.1053/j.gastro.2008.03.037. Epub 2008 Mar 22.
10
IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
J Immunol. 2013 Oct 15;191(8):4184-93. doi: 10.4049/jimmunol.1203449. Epub 2013 Sep 18.

引用本文的文献

1
The bittersweet link between glucose metabolism, cellular microenvironment and viral infection.
Virulence. 2025 Dec;16(1):2554302. doi: 10.1080/21505594.2025.2554302. Epub 2025 Sep 3.
2
MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination.
Mol Ther Nucleic Acids. 2025 Jul 23;36(3):102641. doi: 10.1016/j.omtn.2025.102641. eCollection 2025 Sep 9.
3
Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics.
World J Hepatol. 2025 Jul 27;17(7):107620. doi: 10.4254/wjh.v17.i7.107620.
4
IL-2 and IL-15 augment HBV therapeutic vaccination and PD1 blockade for functional cure in the AAV-HBV mouse model.
Front Immunol. 2025 Jul 16;16:1562107. doi: 10.3389/fimmu.2025.1562107. eCollection 2025.
5
AAV-HBV mouse model replicates the intrahepatic immune landscape of chronic HBV patients at single-cell level.
Front Immunol. 2025 Jun 18;16:1421712. doi: 10.3389/fimmu.2025.1421712. eCollection 2025.
6
Hepatocyte-intrinsic innate immunity in hepatitis B virus infection: A focused review.
World J Hepatol. 2025 Jun 27;17(6):104533. doi: 10.4254/wjh.v17.i6.104533.
7
From Immunity to Oncology: Itaconic Acid as a Driver in HBV-Induced HCC.
J Cell Mol Med. 2025 Jun;29(12):e70612. doi: 10.1111/jcmm.70612.
8
High antigen burden drives CD8+ T cell dysfunction in a mouse model of chronic hepatitis B virus infection.
J Virol. 2025 Jul 22;99(7):e0071125. doi: 10.1128/jvi.00711-25. Epub 2025 Jun 12.
10
Potential role of liver-resident CD3 macrophages in HBV clearance in a mouse hepatitis B model.
JHEP Rep. 2024 Dec 31;7(4):101323. doi: 10.1016/j.jhepr.2024.101323. eCollection 2025 Apr.

本文引用的文献

1
Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.
J Virol. 2002 Jun;76(11):5646-53. doi: 10.1128/jvi.76.11.5646-5653.2002.
3
Noncytolytic control of viral infections by the innate and adaptive immune response.
Annu Rev Immunol. 2001;19:65-91. doi: 10.1146/annurev.immunol.19.1.65.
4
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.
Hepatology. 2000 Nov;32(5):1117-24. doi: 10.1053/jhep.2000.19324.
5
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
J Exp Med. 2000 Oct 2;192(7):921-30. doi: 10.1084/jem.192.7.921.
6
Cytokine-mediated control of viral infections.
Virology. 2000 Aug 1;273(2):221-7. doi: 10.1006/viro.2000.0442.
8
Intrahepatic T cells in hepatitis B: viral control versus liver cell injury.
J Exp Med. 2000 Apr 17;191(8):1263-8. doi: 10.1084/jem.191.8.1263.
9
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.
Am J Pathol. 2000 Apr;156(4):1117-32. doi: 10.1016/s0002-9440(10)64980-2.
10
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections.
J Virol. 2000 Feb;74(3):1495-505. doi: 10.1128/jvi.74.3.1495-1505.2000.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验